Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3781 AL 3795

Voice changes in prodromal Parkinson's disease: Is a new biomarker within earshot?

Postuma RB.

Sleep Med. 2016 Mar;19:148-9. doi: 10.1016/j.sleep.2015.08.019. Epub 2015 Sep 8.

The Role of Vitamin D₃ in the Development and Neuroprotection of Midbrain Dopamine Neurons

Orme RP, Middleditch C, Waite L, Fricker RA.

Vitam Horm. 2016;100:273-97. doi: 10.1016/bs.vh.2015.10.007. Epub 2015 Dec 17.

Evaluation of Models of Parkinson's Disease

Jagmag SA, Tripathi N, Shukla SD, Maiti S, Khurana S.

Front Neurosci. 2016 Jan 19;9:503. doi: 10.3389/fnins.2015.00503. eCollection 2015.

Regional Interplay for Temporal Processing in Parkinson's Disease: Possibilities and Challenges

Schwartze M, Kotz SA.

Front Neurol. 2016 Jan 18;6:270. doi: 10.3389/fneur.2015.00270. eCollection 2015.

Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases

Hornedo-Ortega R, Cerezo AB, Troncoso AM, Garcia-Parrilla MC, Mas A.

Front Microbiol. 2016 Jan 19;6:1565. doi: 10.3389/fmicb.2015.01565. eCollection 2015.

Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain

Merighi A.

Expert Opin Ther Targets. 2016;20(2):193-208. doi: 10.1517/14728222.2016.1085972. Epub 2015 Sep 7.

Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases

Chiurchiù V, Orlacchio A, Maccarrone M.

Oxid Med Cell Longev. 2016;2016:7909380. doi: 10.1155/2016/7909380. Epub 2015 Dec 31.

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease

Blaudin de Thé FX, Rekaik H, Prochiantz A, Fuchs J, Joshi RL.

Neural Plast. 2016;2016:6097107. doi: 10.1155/2016/6097107. Epub 2015 Dec 31.

Preexcitation Syndromes

Bhatia A, Sra J, Akhtar M.

Curr Probl Cardiol. 2016 Mar;41(3):99-137. doi: 10.1016/j.cpcardiol.2015.11.002. Epub 2015 Nov 10.

Outcome measures for Parkinson's disease dementia: a systematic review

Holden SK, Jones WE, Baker KA, Boersma IM, Kluger BM.

Mov Disord Clin Pract. 2016 Jan-Feb;3(1):9-18. doi: 10.1002/mdc3.12225. Epub 2015 Sep 16.

Autoantibodies to Collagen XVII Are Present in Parkinson's Disease and Localize to Tyrosine-Hydroxylase Positive Neurons

Messingham KAN, Aust S, Helfenberger J, Parker KL, Schultz S, McKillip J, Narayanan NS, Fairley JA.

J Invest Dermatol. 2016 Mar;136(3):721-723. doi: 10.1016/j.jid.2015.12.005. Epub 2015 Dec 14.

Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications

Marras C, Herrmann N, Fischer HD, Fung K, Gruneir A, Rochon PA, Rej S, Vigod S, Seitz D, Shulman KI.

Am J Geriatr Psychiatry. 2016 Apr;24(4):301-9. doi: 10.1016/j.jagp.2015.11.004. Epub 2015 Dec 10.

Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease

Rocha JF, Ferreira JJ, Falcão A, Santos A, Pinto R, Nunes T, Almeida L, Soares-da-Silva P.

Clin Pharmacol Drug Dev. 2016 May;5(3):232-40. doi: 10.1002/cpdd.217. Epub 2015 Oct 20.

Manganese toxicity in critical care: Case report, literature review and recommendations for practice

Walter E, Alsaffar S, Livingstone C, Ashley SL.

J Intensive Care Soc. 2016 Aug;17(3):252-257. doi: 10.1177/1751143715622216. Epub 2015 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias